Cargando…
MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma
The degree of metastatic disease varies widely among patients with cancer and affects clinical outcomes. However, the biological and functional differences that drive the extent of metastasis are poorly understood. We analyzed primary tumors and paired metastases using a multifluorescent lineage-lab...
Autores principales: | Maddipati, Ravikanth, Norgard, Robert J., Baslan, Timour, Rathi, Komal S., Zhang, Amy, Saeid, Asal, Higashihara, Taku, Wu, Feng, Kumar, Angad, Annamalai, Valli, Bhattacharya, Saurav, Raman, Pichai, Adkisson, Christian A., Pitarresi, Jason R., Wengyn, Maximilian D., Yamazoe, Taiji, Li, Jinyang, Balli, David, LaRiviere, Michael J., Ngo, Tuong-Vi C., Folkert, Ian W., Millstein, Ian D., Bermeo, Jonathan, Carpenter, Erica L., McAuliffe, John C., Oktay, Maja H., Brekken, Rolf A., Lowe, Scott W., Iacobuzio-Donahue, Christine A., Notta, Faiyaz, Stanger, Ben Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831468/ https://www.ncbi.nlm.nih.gov/pubmed/34551968 http://dx.doi.org/10.1158/2159-8290.CD-20-1826 |
Ejemplares similares
-
Pancreatic cancer survival analysis defines a signature that predicts outcome
por: Raman, Pichai, et al.
Publicado: (2018) -
Pharmacologic Activation of the G Protein–Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma
por: Natale, Christopher A., et al.
Publicado: (2020) -
MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis
por: Barriga, Francisco M., et al.
Publicado: (2022) -
Ordered and deterministic cancer genome evolution after p53 loss
por: Baslan, Timour, et al.
Publicado: (2022) -
Interactive analysis and assessment of single-cell copy-number variations
por: Garvin, Tyler, et al.
Publicado: (2015)